A. Passardi

发表论文 220 篇 · 总被引 3913 次 · h-index 31

代表论文

• Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO. (2025 · Annals of Oncology · 被引 19)
• P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: Role of the A2A/CD39/CD73 axis (2025 · Cell Death and Disease · 被引 17)
• Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE study (2025 · ESMO Open · 被引 12)
• Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study (2026 · Journal of Clinical Oncology · 被引 7)
• Comprehensive genetic and epigenetic characterization of Lynch‐like syndrome patients (2025 · International Journal of Cancer · 被引 7)
• The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies. (2025 · European Journal of Cancer · 被引 6)